Quick Facts

Novartis Q3 Profit Tops View, Sales Match; Backs FY21 View; Mulls Strategic Options For Sandoz

Swiss drug major Novartis (NVS) reported Tuesday that its third-quarter net income climbed 43 percent to $2.76 billion from last year's $1.93 billion. Earnings per share were $1.23, up 45 percent from $0.85 a year ago.

Core net income was $3.83 billion or $1.71 per share, compared to $3.47 billion or $1.52 per share last year.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

More Quick Facts